强的松
医学
醋酸阿比特龙酯
肿瘤科
内科学
危险系数
前列腺癌
中期分析
化疗
泌尿科
外科
癌症
雄激素剥夺疗法
胃肠病学
随机对照试验
置信区间
作者
Charles J. Ryan,Matthew R. Smith,Johann S. de Bono,Arturo Molina,Christopher J. Logothetis,Paul de Souza,Karim Fizazi,Paul N. Mainwaring,Josep M. Piulats,Siobhan Ng,Joan Carles,Peter F.A. Mulders,Ethan Basch,Eric J. Small,Fred Saad,Dirk Schrijvers,Hendrik Van Poppel,Som D. Mukherjee,H. Suttmann,Winald R. Gerritsen
标识
DOI：10.1056/nejmoa1209096
摘要
Abiraterone improved radiographic progression-free survival, showed a trend toward improved overall survival, and significantly delayed clinical decline and initiation of chemotherapy in patients with metastatic castration-resistant prostate cancer. (Funded by Janssen Research and Development, formerly Cougar Biotechnology; ClinicalTrials.gov number, NCT00887198.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
伯克利芙蓉王
学霸业
Criminology34
czx
mmmm
无极微光
yanaiqi
kaio_escolar
锅包肉
果果123
忧心的曼凝
arniu2008
DIVINEDC
GingerF
端庄问蕊
红伞伞白杆杆
DW
ahj
Rita
supshuo
皖公网安备34019202002308
